Xenous Holdings Reports $15,519 Net Loss in Q3 FY2026 as Deficit Widens

Xenous Holdings, Inc., a Nevada-incorporated shell company, reported a net loss of $15,519 for the three months ending December 31, 2025, compared to a loss of $14,894 in the same quarter a year earlier. The company generated no revenue during the period. Read more earnings reports.

For the nine months ending December 31, 2025, Xenous Holdings recorded a cumulative net loss of $46,505, roughly flat with the $46,049 loss reported in the comparable nine-month period of the prior fiscal year. Operating expenses for the nine-month period totaled $46,505, compared to $46,049 in the year-ago period.

The company's balance sheet as of December 31, 2025 showed zero assets and total liabilities of $950,127, up from $903,622 as of March 31, 2025. Stockholders' deficit deepened to negative $950,127 from negative $903,622 over the same span. The company held no cash or cash equivalents at quarter end.

Retained deficit stood at negative $1.26 million as of December 31, 2025, compared to negative $1.21 million at the end of the prior fiscal year. The company has 760.25 million common shares outstanding, with a par value contributing $760,250 to the equity section.

Cash used in operations for the nine months was $46,565, slightly better than the $49,057 outflow in the year-ago period. The company offset this entirely with $46,565 in cash from financing activities, matching the operating burn dollar for dollar.

Diluted loss per share was $0.00 for both the three-month and nine-month periods ending December 31, 2025, calculated on 760.25 million weighted average shares outstanding. The company is classified as a non-accelerated filer and a small business reporting entity.

Key Financial Metrics